ORX-142

N/A

Report date: 2025/06/23 09:09:49
NME

Base Information

Drug NameORX-142
Drug Alias NameORX142ORX-142
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 2 agonists
TargetsOrexin receptor type 2
Therapy Area/IndicationsMental DisordersNerve DegenerationDisorders of Excessive Somnolence +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCentessa Pharmaceuticals Plc
China Registration ClassN/A

Develop Information

Active CompaniesCentessa Pharmaceuticals (UK) LtdCentessa Pharmaceuticals Plc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationDisorders of Excessive Somnolence
Inactive IndicationsMental DisordersNeurodegenerative DiseasesNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A